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 This paper reflects the need to regulate the precursors critical to clandestine 
manufacture of methamphetamine, ephedrine and pseudoephedrine. The research 
draws upon historical evidence of governmental initiatives taken to curtail 
methamphetamine production, the results, and the efforts of people intent on producing 
methamphetamine have taken to circumvent legislation. The research also reflects in 
broad terms the devastating sociological and environmental negative effects of 
clandestinely produced methamphetamine as well as the dangers posed to first 
responders.  
  Research documents valid uses for consumer products containing ephedrine and 
pseudoephedrine. This paper allows for the continued, restricted use of such products. 
Products containing the crucial precursors ephedrine and pseudoephedrine should be 
further regulated to limit the impact of clandestine methamphetamine laboratories.  The 
consulted research material includes books, articles, web sites, and congressional 
testimony. 
The data presented in this research paper overwhelmingly support a bill be 
introduced and passed in Texas to regulate and classify ephedrine and 
pseudoephedrine, and products containing these precursors, as a dangerous drug, 
requiring a prescription by a physician. The prescription requirement will not eliminate 
methamphetamine in Texas, or in the United States, but will help eliminate the number 
of clandestine methamphetamine labs encountered by first responders, neighbors, and 
children.  
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This research paper supports the need for swift action to regulate precursor 
chemicals of illicitly manufactured methamphetamine.  It demonstrates how the history 
of the regulation of ephedrine and pseudoephedrine has impacted the availability of 
illicit methamphetamine and the prevalence of clandestine methamphetamine 
laboratories.  The data also demonstrates how other state regulations have had 
significant, lasting impacts on methamphetamine production.  Products containing 
ephedrine and pseudoephedrine should be further regulated to reduce the hazards of 
methamphetamine laboratories and discourage methamphetamine production.  
The research in this paper is relevant to law enforcement across the United 
States.  Abuse of methamphetamine is a serious and growing problem affecting the 
United States, with every indication of widespread abuse increasing (National Institute 
on Drug Abuse, 2006).   In fact, the current level of abuse in the United States has been 
referred to as a dual epidemic with the potential to destroy the physical, mental, 
economic, and social well being of those engaged in the abuse of methamphetamine 
(Halkitis, 2009).   Despite increasing awareness of the drug and the regulation of 
methamphetamine precursors, methamphetamine continues to menace American 
society.   Current efforts to control methamphetamine and its precursors have yet to 
demonstrate a sustained impact on the production and availability of methamphetamine, 
and more restrictive measures must be taken.  There will be a number of methods of 
inquiry utilized during the research portion of this paper.  The consulted research 




Methamphetamine abuse leads to devastating social effects, including medical 
issues, such as psychotic behavior; transmission of infectious disease; malnutrition; and 
severe dental problems; as well as other social ramifications, such as increased crime 
rates, unemployment, and spouse and child abuse.   The clandestine manufacture of 
methamphetamine produces hazards to the persons involved in the manufacture and 
persons in the vicinity of a location used to manufacture methamphetamine.   Every 
pound of methamphetamine produced at a clandestine laboratory produces six pounds 
of hazardous waste (National Institute on Drug Abuse, 2006).  In addition, significant 
hazards exist to first responders arriving at the scene of a methamphetamine laboratory.  
The production of methamphetamine requires the use of hazardous chemicals, such as 
ether and ammonia.  The first responders may or may not be aware of the existence of 
such hazards prior to their arrival.   Respiratory exposures of many of these chemicals 
in various stages of chemical reaction require the use of respiratory equipment to 
prevent injury to first responders.   This waste includes corrosive liquid, acids vapors, 
heavy metals, solvents, and other harmful materials that can cause death or 
disfigurement when contact is made with skin or breathed into the lungs.  The vapors 
created by the illicit production of methamphetamine can attack mucous membranes, 
skin, eyes, and the respiratory tract, even if the laboratory is not in an actual 
“production” stage. 
A brief history of methamphetamine and efforts to control it may assist in a better 
understanding of the evolution of the current epidemic.  Amphetamine, which is similar 
to Methamphetamine, was first synthesized in Germany in 1887.  Methamphetamine, 
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which closely resembles amphetamine in chemical structure, was first synthesized in 
Japan in 1919.   Methamphetamine, which is derived from ephedrine or 
pseudoephedrine, which in turn are derivatives of the ephedra plant, was used by the 
Japanese military and civilian population to increase performance in war-time 
operations during World War II.  Other forms of Central Nervous Stimulants, such as 
amphetamines, were also used by other nations during the war.  Following World War 
II, forms of amphetamine such as Dexadrine and Methedrine were used by persons in 
the United States.  Truck drivers, students, and athletes would use these substances to 
stay awake, improve performance, and concentration.  (Covey, 2007)   
Amphetamine tablets were widely available without a prescription until 1951, with 
inhalers available without a prescription until 1959 (Klee, 1997).   In 1970, the 
Comprehensive Drug Abuse Prevention and Control Act, also referred to as the 
Controlled Substances Act; was passed which restricted the sales of some precursors 
such as ephedrine and pseudoephedrine to amphetamine and methamphetamine 
(Covey, 2007).   This was one of the first regulations passed by Congress in an effort to 
limit the clandestine manufacture of methamphetamine.  
Following the restriction of ephedrine in 1970, pseudoephedrine became the 
primary precursor for the production of methamphetamine.  Use of methamphetamine 
declined following the 1970 Controlled Substance Act (Covey, 2007).  According to the 
Department of Justice (“U.S. Chemical Control”, 2011, para 3), “DEA chemical control 
was initiated in the United States with the passage of the Chemical Diversion and 
Trafficking Act of 1988 (CDTA) that became effective on August 1, 1989”.  This 
measure provided record keeping requirements imposed on chemicals and precursors 
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to methamphetamine while exempting certain medications available over the counter 
without a prescription (“U.S. Chemical Control”, 2011, para 3).  This Act was designed 
so there would be a sufficient amount of the regulated chemicals and precursors used 
for medical and other legitimate purposes.  
The Methamphetamine Control Act of 1996 was passed by Congress following 
the emergence of “super labs” in California and Mexico.  “Super Labs” are clandestine 
laboratories having a production capacity of ten pounds of methamphetamine or more 
(O'Conner, 2007) and were believed to have been producing approximately eighty five 
percent of all methamphetamine in the United States.   A shift in methamphetamine 
production in the 1990’s, however, indicated an increase from the “super labs” to 
smaller clandestine laboratories  (Covey, 2007).   The last major federal inititiative was 
the Combat Methamphetamine Epidemic Act 2005 which was signed into law on March 
9, 2006 (Covey, 2007).   
In Texas, laws were enacted in 2005 in an effort to regulate the purchase of 
products containing ephedrine and pseudoephedrine to combat the illicit manufacture of 
methamphetamine.   Texas Health and Safety Code (H.S.) Chapter 486 (2005) 
regulates the sale of products containing ephedrine and pseudoephedrine by 
pharmacies and other retail establishments.  This law restricts sales of products 
containing these substances to two packages of product, or of a maximum of 6 grams of 
ephedrine, pseudoephedrine and nor pseudoephedrine in any given product.    H.S. 
Chapter 486 also mandates that products containing ephedrine and pseudoephedrine 
be stored behind a pharmacy or sales counter, or be stored in a locked display case 
within 30 feet of the sales or pharmacy counter.  In addition, Texas Health and Safety 
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Code Chapter 486 (2005) requires persons purchasing these products be older than 16 
years of age, present a valid photo identification, and sign for the purchase.    Texas 
Health and Safety Code Chapter 486 (2005) also provides the retailer or pharmacy 
make a record of the date of sale, including the name of the purchaser, the date of the 
purchase, and a description and the amount of the item purchased. 
Following each of these regulations, the availability of illicitly manufactured 
methamphetamine was reduced, if only temporarily.  For example, the Drug 
Enforcement Administration shut down two major domestic suppliers of precursors of 
methamphetamine following the Chemical Diversion and Trafficking Act of 1993.  
According to Dobkin (2009), the cost and purity of methamphetamine in California 
following the raids, and subsequently the availability and purity, as well as arrests for 
methamphetamine were reduced significantly.  The methamphetamine market 
recovered in California after approximately 18 months, suggesting the producers of the 
drug were able to locate suitable substitute supplies of precursors from other sources.  
(Dobkin, 2009)  
There are numerous ways to manufacture methamphetamine.  The two most 
common methods are discussed here.  The first method discussed is referred to as the 
“P2P” method. This method is based on the chemical P2P (phenalacetone or phenyl-2-
propanone) and methylamine. The U.S. government took steps restricting the sale of 
P2P and methylamine in response to the clandestine manufacture of methamphetamine 
in 1980, effectively eliminating this method as a viable means of illicit production in the 
United States  (Weisheit, 2010).  The second, and presently the most common method 
of illicit methamphetamine production, is the ephedrine reduction method.  This method 
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includes the “Red Phosphorous” and “Birch” methods (Weisheit, 2010).  The ephedrine 
reduction method simply removes an oxygen molecule from ephedrine or 
pseudoephedrine and creates methamphetamine (see Appendix). The Red 
Phosphorous and Birch Methods both reduce psedoephedrine to methamphetamine 
through slightly differing chemical reactions.  
The relevance of the regulation of ephedrine and pseudoephedrine as it relates 
to the abuse and illicit manufacture of methamphetamine is crucial to the control of 
methamphetamine and the reduction of negative impacts of clandestine 
methamphetamine laboratories.  Currently, ephedrine and pseudoephedrine are the key 
components utilized in the clandestine manufacture of methamphetamine.  While many 
components and chemical compounds such as alcohol, ether, acetone, anhydrous 
ammonia, muriatic acid, lithium metal, etc., used in the clandestine manufacture of 
methamphetamine can readily be substituted; ephedrine and pseudoephedrine, cannot 
be easily replaced in the chemical process to produce methamphetamine.  Without 
ephedrine and ephedrine based products, methamphetamine cannot be easily 
produced with currently unregulated and commercially available ingredients.  Efforts to 
control precursors and to increase penalties for the manufacture of methamphetamine 
have undoubtedly played a role in reducing the number of domestic methamphetamine 
laboratories, though the precise extent of that impact is unclear.  The 2009 National 
Methamphetamine Threat Assessment report indicated that the number of domestic 
methamphetamine laboratories increased in 2008 (National Drug Intelligence Center, 
2011).  One state, Indiana, saw a 31 percent increase in the number of 
methamphetamine laboratories seized between 2007 and 2008 (Weisheit, 2010). 
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Products containing ephedrine and pseudoephedrine should be further regulated 
to reduce the hazards of methamphetamine laboratories and discourage 
methamphetamine production.   This may be accomplished by classifying medicinal 
products containing ephedrine and pseudoephedrine as a Scheduled drug requiring a 
prescription in the State of Texas.  To date, two states, Oregon and Mississippi, have 
enacted legislation requiring products containing ephedrine, pseudoephedrine, and nor 
pseudoephedrine to be dispensed only by a prescription issued by a physician.  The 
Mississippi legislation of HB 512 became effective July 1, 2010.  The Oregon legislation 
went into effect on July 1, 2006.   The Department of Justice reported that following the 
enactment of this law, Oregon demonstrated a “92 percent decrease in the number of 
methamphetamine laboratories seized, a 22 percent decrease in property crime, and a 
7 percent decrease in violent crime” (“Drug Coast HIDTA”, 2010, p. 4).   
Most recently, the Texas legislature has passed legislation requiring the 
electronic logging of sales of ephedrine, pseudoephedrine, and norpseudoephedrine 
under the Texas Helath and Safety Code Section 486.0141 (2005). This legislation was 
passed into law September 1st, 2011 and went into effect January 1st, 2012.  At the time 
of this research, it is still too early to tell if this law will have the desired effect of limiting 
ephedrine, pseudoephedrine or norpseudoephedrine in the illicit manufacture of 
methamphetamine.  
COUNTER POSITION 
As cited by Weisheit (2010), there are “raised doubts” about claims that 
restricting precursors for methamphetamine production in California affected supply of 
the drug, which suggests that the restrictions had no effect on supply, noting “following 
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precursor regulation, the price of methamphetamine went down” (p. 8).  Current data 
indicates that most of the methaphetamine available in the United States is produced in 
Mexico or the American Southwest (“Meth Kills,” n.d.).  Methamphetamine produced in 
these regions are typically from “super labs” that can produce in excess of ten pounds 
of methamphetamine per “cook”. This argument, while valid at the time of the research, 
predated the ban of ehpedrine and pseudoephedrine precursors in Mexico.  
According to the Meth Lab Homes websites, many producers of illicit 
methamphetamine have turned to “smurfing” as a means to obtain the ephedrine and 
pseudoephedrine necessary to produce methamphetamine.  The Department of Justice 
described smurfing as “a method used by some methamphetamine and precursor 
chemical traffickers to acquire large quantities of pseudoephedrine. Individuals 
purchase pseudoephedrine in quantities at or below legal thresholds from multiple retail 
locations” (“Meth Kills,” n.d.). 
Smurfing and “super labs” have shown an increase in 2008 and 2009 in 
California, with evidence supporting that even the homeless population is being 
recruited to purchase products containing psedoephedrine for use in these labs (“U.S. 
Border Security and California Meth Labs,” 2010).  According “U.S. Border Security and 
California Meth Labs,” (2010),  smurfing activity and the resulting meth lab dump sites 
actually increased in California in 2008 and 2009.  Meth Lab Homes went on to indicate 
that the ban on pseudoephedrine products in Mexico had actually caused an increase in 
smurfing activities in California and “will most likely limit the availability of the chemical 
in that country, thereby limiting any incentive for Mexican methamphetamine producers 
to move their operations back to Mexico” (para. 13)  
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Also evident in “smurfing” are the violations of retailers to enforce limits of 
ephedrine and pseudoephedrine products. Retailers can accrue considerable profits 
from the sale of such products.  According to the National Association of Boards of 
Pharmacy (NABP), CVS Pharmacy was investigated for violating electronic 
pseudoephedrine logging requirements, from September 2007 to November 2008, 
which failed to prevent multiple purchases by an individual on the same day. CVS 
Pharmacy was fined $77.6 million “in penalties and forfeitures”. The NABP went on to 
quote the Department of Justice report’s that “CVS’s failure to ensure compliance with 
the law led to large amounts of PSE (pseudoephedrine) being supplied to 
methamphetamine traffickers and an increase in methamphetamine production in 
California” (NABP, 2010, p. 1). CVS was also alleged to have earned $2.6 million from 
the illegal sales.  
RECOMMENDATION 
 Ephedrine and pseudoephedrine are crucial to domestic methamphetamine 
production. Incremental regulations of ephedrine and pseudoephedrine have 
demonstrated decreases in illicit methamphetamine production, if only temporarily. 
Require products containing ephedrine or pseudoephedrine to be issued only by 
prescription.  The State of Oregon enacted law in 2006 requiring all cold, allergy, and 
sinus medications containing pseudoephedrine can only be obtained in Oregon with a 
prescription by a physician.  According to testimony presented to the Oregon Senate 
Judiciary Committee, prescription restrictions for ephedrine and pseudoephedrine 
containing products decreased the prevalence of clandestine methamphetamine 
laboratories and of illicitly produced methamphetamine.  In addition, for the period of 
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July 1, 2006 through the date of testimony May 8, 2007, clandestine methamphetamine 
laboratories were “virtually eliminated” and of those labs located during the same time 
frame, all had precursor chemicals of ephedrine or pseudoephedrine that could be 
traced to sources before the enactment of the Oregon law, or were from “smurfing” in 
other locations (“Written Testimony,” 2007).   The data presented in this research paper 
overwhelmingly support a bill be introduced and passed in Texas to regulate and 
classify ephedrine and pseudoephedrine, and products containing these precursors, as 
a dangerous drug, requiring a prescription by a physician. The prescription requirement 
will not eliminate methamphetamine in Texas, or in the United States, but will help 
eliminate the number of clandestine methamphetamine labs encountered by first 
responders, neighbors, and children.  
 11 
REFERENCES 
Covey, H. C. (2007). The Methamphetamine Crisis: Strategies to Save Addicts, 
Families, and Communities. Wesport: Praeger Publishers. 
Dobkin, C. A. (2009, March 1). The War on Drugs: Methamphetamine, Public Health, 
and Crime. Retrieved from National Institute of Health Public Access 
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2883188/pdf/nihms197874.pdf 
Drug coast HIDTA drug market analysis 2010. (2010, May). Retrieved from 
http://www.justice.gov/ndic/pubs40/40386/product.htm 
Drug Enforcement Administration. (n.d.). Fact sheet. Retrieved from 
http://www.justice.gov/dea/pubs/pressrel/methfact01.html 
Halkitis, P. N. (2009). Methamphetamine addiction. Washington, DC: American 
Psychological Association. 
History of meth. (n.d.). Retrieved April 29, 2012 from http://meth-kills.org/history-of-
 meth.html 
U.S. border Security and California meth labs. (2010, January). Retrieved February 1, 
2011 from http://methlabhomes.com/2010/01/u-s-border-security-and-california-
meth-labs/ 
Should products containing pseudoephedrine be available only by prescription?  (2011, 
January 13). Retrieved February 1, 2011 from 
http://methlabhomes.com/2011/01/should-products-containing-pseudoephedrine-
be-available-only-by-prescription/ 
O'Conner, J.C. (2007). Developing lasting legal solutions to the dual epidemics of 
methamphetamine production and use. North Dakota Law Review, 82, 1165. 
 12 
Klee, H. (1997). Amphetamine misuse: International perspectives on current trends. 
Amsterdam: Harwood Academic Publishers. 
Methamphetamine Facts and Figures. (n.d.). Retrieved from 
http://www.whitehousedrugpolicy.gov/drugfact/methamphetamine/methampheta
mine_ff.html 
NABP. (2010, October 21). CVS fined for failing to enforce PSE sales limits. Retrieved 
from http://www.nabp.net/news/cvs-fined-for-failing-to-enforce-pse-sales-limits/ 
National Institute on Drug Abuse.  (2006). Methamphetamine abuse and addiction 
(Report 2011-003317-001).  Retrieved from 
http://www.drugabuse.gov/ResearchReports/methamph/methamph.html 
National Drug Intelligence Center (NDIC).  (2011, August). National drug threat 
assessement 2011 (Report 2011-Q0317-001). Retrieved 
http://www.justice.gov/dea/concern/18862/index.htm 
Texas Health and Safety Code, Title 6, SubChapter C, Chapter 486. (2005). 
U.S. Chemical Control. (2011, January 29). Retrieved from 
http://www.justice.gov/dea/concern/chemical_control.html 
Weisheit, R. A. (2010). Methamphetamine Laboratories: The Geography of Drug 
Production. Western Criminology Review, 11(2),9-26 .  
Written Testimony of Rob Bovett before the Senate Judiciary Committe Regarding HB 
2782,Oregon State Senate Judiciary Committee. (2007, May 8). Retrieved from 
http://www.oregondec.org/legislation/HB2782-ONEA-SenateTestimony.pdf 
 
 
 
 13 
APPENDIX Methamphetamine 
 
 
 
